Jefferies initiates coverage on Complete Genomic (NASDAQ: GNOM) with a Buy rating and $13 price target, representing 89% upside.

This article: 101 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE